In our study, the B. adolescentis-pretreated group showed reduced Iba1 levels following CRS, which is in agreement with previously published studies that have highlighted the potential therapeutic efficacy of targeting central inflammatory processes, particularly those mediated by microglia, in depression (Alcocer-Gómez et al., 2016). This evidence concerns the gene AIF1 and depressive symptom measurement.